AmerisourceBergen Corporation (ABC): Price and Financial Metrics

AmerisourceBergen Corporation (ABC)

Today's Latest Price: $107.09 USD

1.75 (-1.61%)

Updated Jan 27 3:24pm

Add ABC to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

ABC Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ABC is -186.37 -- better than only 0.18% of US stocks.
  • With a price/sales ratio of 0.12, Amerisourcebergen Corp has a higher such ratio than only 2.01% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 17.81 for Amerisourcebergen Corp; that's greater than it is for 97.7% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Amerisourcebergen Corp are CCLP, GSS, CHWY, MKD, and WAT.
  • Visit ABC's SEC page to see the company's official filings. To visit the company's web site, go to

ABC Stock Price Chart Interactive Chart >

Price chart for ABC

ABC Price/Volume Stats

Current price $107.09 52-week high $112.48
Prev. close $108.84 52-week low $72.06
Day low $106.61 Volume 566,654
Day high $109.76 Avg. volume 1,521,893
50-day MA $102.27 Dividend yield 1.62%
200-day MA $98.37 Market Cap 21.87B

AmerisourceBergen Corporation (ABC) Company Bio

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The company was founded in 1985 and is based in Chesterbrook, Pennsylvania.

ABC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$107.09$35.82 -67%

Below please find a table outlining a discounted cash flow forecast for ABC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Amerisourcebergen Corp ranked in the 27th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for ABC, they are:

  • The company's compound free cash flow growth rate over the past 5.54 years comes in at -0.07%; that's greater than merely 16.83% of US stocks we're applying DCF forecasting to.
  • Amerisourcebergen Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -37.46. This coverage rate is greater than that of only 3.38% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • As a business, Amerisourcebergen Corp experienced a tax rate of about 27% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 90.07% of stocks generating free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Amerisourcebergen Corp? See DYNT, ABT, CDNA, CPIX, and HSIC.

ABC Latest News Stream

Event/Time News Detail
Loading, please wait...

ABC Latest Social Stream

Loading social stream, please wait...

View Full ABC Social Stream

Latest ABC News From Around the Web

Below are the latest news stories about Amerisourcebergen Corp that investors may wish to consider to help them evaluate ABC as an investment opportunity.

Trevena's Catalyst-Filled Q1

Although Q4 brought the much-awaited start to commercialization of OLINVYK following DEA scheduling during the middle of the quarter, shares of Trevena (TRVN) have drifted back towards the low-$2 range. With the recent consolidation, Trevena could offer an interesting buy point ahead of full commercial launch, top-line data for TRV027...

Damien Robbins on Seeking Alpha | January 25, 2021

Why AmerisourceBergen (ABC) Could Beat Earnings Estimates Again

AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | January 25, 2021

Here's Why You Should Retain AmerisourceBergen (ABC) Now

AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

Yahoo | January 25, 2021

Anthem (ANTM) to Report Q4 Earnings: What's in the Cards?

Anthem (ANTM) is likely to have witnessed increased revenues and a rise in membership during Q4, offset by an escalating expense level.

Yahoo | January 22, 2021

Compounding Pharmacies Market to Set New Growth Story | AmerisourceBergen, Rx3 Pharmacy, Agbi’s Sterile Compounding Pharmacy

Global Compounding Pharmacies Market Report 2021 is latest research study released by AMA evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities,

OpenPR | January 21, 2021

Read More 'ABC' Stories Here

ABC Price Returns

1-mo 10.63%
3-mo 13.69%
6-mo 7.77%
1-year 22.32%
3-year 7.15%
5-year 30.63%
YTD 9.54%
2020 17.03%
2019 16.48%
2018 -17.57%
2017 19.51%
2016 -23.32%

ABC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ABC Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9793 seconds.